CD274 and neoplasm: Indeed, it was demonstrated that a high level of PD-L1-expressing TEXs in blood, as a variant of secreted PD-L1, could neutralize the administrated anti-PD-1 antibodies (74) before they reached tumor tissues, thereby resulting in poor response and outcomes (75).